Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Buys 36 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% during the third quarter, HoldingsChannel.com reports. The fund owned 3,583 shares of the healthcare conglomerate’s stock after purchasing an additional 36 shares during the quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in UnitedHealth Group were worth $2,009,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of UNH. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth $27,000. Global Wealth Strategies & Associates grew its stake in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares in the last quarter. Macroview Investment Management LLC grew its stake in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares in the last quarter. West Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth $32,000. Finally, Delos Wealth Advisors LLC grew its stake in shares of UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently commented on UNH shares. Truist Financial reaffirmed a “buy” rating and set a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. UBS Group dropped their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Barclays dropped their price target on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Finally, KeyCorp assumed coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Up 1.0 %

Shares of NYSE:UNH traded up $5.36 during trading hours on Wednesday, hitting $567.49. The company’s stock had a trading volume of 278,658 shares, compared to its average volume of 3,902,051. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $608.63. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The company has a market capitalization of $524.03 billion, a price-to-earnings ratio of 36.62, a P/E/G ratio of 1.66 and a beta of 0.58. The firm’s fifty day moving average price is $582.88 and its 200 day moving average price is $540.32.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.56 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.48%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.